Hereditary Breast and Ovarian Cancer , 1st ed. 2021 Molecular Mechanism and Clinical Practice
Coordonnateurs : Nakamura Seigo, Aoki Daisuke, Miki Yoshio
15 Germline Findings from Genetic Testing for Breast Cancer 16 Hereditary Breast and Ovarian Cancer (HBOC) Database 17 Ethical Issues: Overview in Genomic analysis and Clinical Context
18 PARP Inhibitors-Mechanism of action 19 PARPi - Efficacy in Hereditary Breast Cancer 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer
Department of Breast Surgical Oncology
Showa University, School of Medicine
Tokyo, Japan
Daisuke Aoki
Department of Obstetrics and Gynecology,
Keio University School of Medicine,
Tokyo, Japan
Yoshio Miki
Department of Molecular Genetics, Medical Research Institute,
Tokyo Medical and Dental University,
Tokyo, Japan
Discusses the molecular mechanisms, genetic testing and counseling, and variants of unknown significance
Includes a special chapter on the recent findings from the HBOC database, ethical issues and the parp inhibitors
Appeals to breast surgeons, medical oncologists, gynecological oncologists and genetic counselors
Date de parution : 10-2022
Ouvrage de 324 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 116,04 €
Ajouter au panierDate de parution : 10-2021
Ouvrage de 324 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panier